|
1
|
Siegel R, Ward E, Brawley O and Jemal A:
Cancer statistics, 2011: the impact of eliminating socioeconomic
and racial disparities on premature cancer deaths. CA Cancer J
Clin. 61:212–236. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Fan L, Wang H, Xia X, Rao Y, Ma X, Ma D,
Wu P and Chen G: Loss of E-cadherin promotes prostate cancer
metastasis via upregulation of metastasis-associated gene 1
expression. Oncol Lett. 4:1225–1233. 2012.PubMed/NCBI
|
|
3
|
Wu KJ, Zeng J, Zhu GD, Zhang LL, Zhang D,
Li L, Fan JH, Wang XY and He DL: Silibinin inhibits prostate cancer
invasion, motility and migration by suppressing vimentin and MMP-2
expression. Acta Pharmacol Sin. 30:1162–1168. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Nelson CJ, Lee JS, Gamboa MC and Roth AJ:
Cognitive effects of hormone therapy in men with prostate cancer: a
review. Cancer. 113:1097–1106. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Mundy GR: Metastasis to bone: causes,
consequences and therapeutic opportunities. Nat Rev Cancer.
2:584–593. 2002. View
Article : Google Scholar : PubMed/NCBI
|
|
6
|
Logothetis CJ and Lin SH: Osteoblasts in
prostate cancer metastasis to bone. Nat Rev Cancer. 5:21–28. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Friedman RC, Farh KK, Burge CB and Bartel
DP: Most mammalian mRNAs are conserved targets of microRNAs. Genome
Res. 19:92–105. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Lewis BP, Burge CB and Bartel DP:
Conserved seed pairing, often flanked by adenosines, indicates that
thousands of human genes are microRNA targets. Cell. 120:15–20.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Stefani G and Slack FJ: Small non-coding
RNAs in animal development. Nat Rev Mol Cell Biol. 9:219–230. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Ambros V: The functions of animal
microRNAs. Nature. 431:350–355. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
He L and Hannon GJ: MicroRNAs: small RNAs
with a big role in gene regulation. Nat Rev Genet. 5:522–531. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Schickel R, Boyerinas B, Park SM and Peter
ME: MicroRNAs: key players in the immune system, differentiation,
tumorigenesis and cell death. Oncogene. 27:5959–5974. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Calin GA and Croce CM: MicroRNA signatures
in human cancers. Nat Rev Cancer. 6:857–866. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Calin GA, Sevignani C, Dumitru CD, Hyslop
T, Noch E, Yendamuri S, Shimizu M, Rattan S, Bullrich F, Negrini M
and Croce CM: Human microRNA genes are frequently located at
fragile sites and genomic regions involved in cancers. Proc Natl
Acad Sci USA. 101:2999–3004. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Zhang H, Cai X, Wang Y, Tang H, Tong D and
Ji F: microRNA-143, down-regulated in osteosarcoma, promotes
apoptosis and suppresses tumorigenicity by targeting Bcl-2. Oncol
Rep. 24:1363–1369. 2010.PubMed/NCBI
|
|
16
|
Clape C, Fritz V, Henriquet C, Apparailly
F, Fernandez PL, Iborra F, Avances C, Villalba M, Culine S and
Fajas L: miR-143 interferes with ERK5 signaling and abrogates
prostate cancer progression in mice. PLoS One. 4:e75422009.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Iio A, Nakagawa Y, Hirata I, Naoe T and
Akao Y: Identification of non-coding RNAs embracing
microRNA-143/145 cluster. Mol Cancer. 9:1362010. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Gregersen LH, Jacobsen A, Frankel LB, Wen
J, Krogh A and Lund AH: MicroRNA-143 down-regulates Hexokinase 2 in
colon cancer cells. BMC Cancer. 12:2322012. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Xu B, Niu X, Zhang X, Tao J, Wu D, Wang Z,
Li P, Zhang W, Wu H, Feng N, Wang Z, Hua L and Wang X: miR-143
decreases prostate cancer cells proliferation and migration and
enhances their sensitivity to docetaxel through suppression of
KRAS. Mol Cell Biochem. 350:207–213. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Peng X, Guo W, Liu T, Wang X, Tu X, Xiong
D, Chen S, Lai Y, Du H, Chen G, Liu G, Tang Y, Huang S and Zou X:
Identification of miRs-143 and -145 that is associated with bone
metastasis of prostate cancer and involved in the regulation of
EMT. PLoS One. 6:e203412011. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Osaki M, Takeshita F, Sugimoto Y, Kosaka
N, Yamamoto Y, Yoshioka Y, Kobayashi E, Yamada T, Kawai A, Inoue T,
Ito H, Oshimura M and Ochiya T: MicroRNA-143 regulates human
osteosarcoma metastasis by regulating matrix metalloprotease-13
expression. Mol Ther. 19:1123–1130. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Lafleur MA, Drew AF, de Sousa EL, Blick T,
Bills M, Walker EC, Williams ED, Waltham M and Thompson EW:
Upregulation of matrix metalloproteinases (MMPs) in breast cancer
xenografts: a major induction of stromal MMP-13. Int J Cancer.
114:544–554. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Morgia G, Falsaperla M, Malaponte G,
Madonia M, Indelicato M, Travali S and Mazzarino MC: Matrix
metalloproteinases as diagnostic (MMP-13) and prognostic (MMP-2,
MMP-9) markers of prostate cancer. Urol Res. 33:44–50. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Liotta LA and Stetler-Stevenson WG:
Metalloproteinases and cancer invasion. Semin Cancer Biol.
1:99–106. 1990.PubMed/NCBI
|
|
25
|
Liotta LA, Steeg PS and Stetler-Stevenson
WG: Cancer metastasis and angiogenesis: an imbalance of positive
and negative regulation. Cell. 64:327–336. 1991. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Moses MA, Wiederschain D, Loughlin KR,
Zurakowski D, Lamb CC and Freeman MR: Increased incidence of matrix
metalloproteinases in urine of cancer patients. Cancer Res.
58:1395–1399. 1998.PubMed/NCBI
|
|
27
|
Morrison C, Mancini S, Cipollone J,
Kappelhoff R, Roskelley C and Overall C: Microarray and proteomic
analysis of breast cancer cell and osteoblast co-cultures: role of
osteoblast matrix metalloproteinase (MMP)-13 in bone metastasis. J
Biol Chem. 286:34271–34285. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Pendas AM, Uria JA, Jimenez MG, Balbin M,
Freije JP and Lopez-Otin C: An overview of collagenase-3 expression
in malignant tumors and analysis of its potential value as a target
in antitumor therapies. Clin Chim Acta. 291:137–155. 2000.
View Article : Google Scholar : PubMed/NCBI
|
